MCET Financials: Multicell Technologies Inc AI Analysis

Home

Stock

MCET

Financials

MCET Financial

Multicell Technologies Inc

Overview Forecast Earnings Dividends Financials

Income

Balance sheet

Cash flow

Annual

Quarterly

MCET Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	11/30/2014	11/30/2013	11/30/2012	11/30/2011	11/30/2010
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	0	--	--	--	--	--
Gross Profit	0	--	--	--	--	--
Selling, General & Admin	0	0	1	1	1	0
Research & Development	0	0	0	0	0	0
Operating Expenses	0	0	1	1	2	1
Other Non Operating Income (Expenses)	--	--	--	0	0	0
Pretax Income	0	0	-1	-1	-1	-1
Income Tax Expense	--	--	0	0	0	0
Net Income	0	0	-1	-1	-1	-1
Net Income Growth	--	-100%	0%	0%	0%	--
Shares Outstanding (Diluted)	5,000.94	3,726.16	1,915.73	1,035.17	692.92	379.78
Shares Change (YoY)	-1%	95%	85%	49%	82%	103%
EPS (Diluted)	0	0	0	0	0	0
EPS Growth	--	-83%	-50%	-54%	-24%	-28.99%
Free Cash Flow	0	-1	-1	0	-1	0
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	0%	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	0	--	--	-1	-2	-1
EBITDA Margin	0%	--	--	0%	0%	0%
D&A For EBITDA	0	--	--	0	0	0
EBIT	0	0	-1	-1	-2	-1
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	0%	0%	0%	0%

Follow-Up Questions

What are Multicell Technologies Inc's key financial statements?



According to the latest financial statement (Form-10K), Multicell Technologies Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for MCET?



Multicell Technologies Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Multicell Technologies Inc's revenue broken down by segment or geography?



Multicell Technologies Inc largest revenue segment is Facilities Cleaning, at a revenue of 56,016,000 in the most earnings release.For geography, Singapore is the primary market for Multicell Technologies Inc, at a revenue of 72,042,000.

Is Multicell Technologies Inc profitable?



no, according to the latest financial statements, Multicell Technologies Inc has a net loss of $0

Does Multicell Technologies Inc have any liabilities?



no, Multicell Technologies Inc has liability of 0

How many outstanding shares for Multicell Technologies Inc?



Multicell Technologies Inc has a total outstanding shares of 4,552.8

Key Stats

Prev.Close

Open

Day's Range

$0 - $0

52 week range

$0 - $0

Volume

20.0K

Avg.Volume

Dividend yield

EPS (TTM)

-0.00

Market Cap

$50.0K

What is MCET?

MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. The company is headquartered in Woonsocket, Rhode Island. The firm and its subsidiaries are developing therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer and interventional cardiology, and peripheral vessel applications. The firm's portfolio of lead drug candidates is in various stages of discovery optimization, and preclinical and clinical development, and includes MCT-125, MCT-465, MCT-475 and MCT-485. MCT-125 is a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue. MCT-465 is a preclinical synthetic double-stranded ribonucleic acid (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers. MCT-475 is a discovery-stage antibody therapeutic candidate used in combination with dsRNA for the treatment of solid tumor cancers. MCT-485 is a discovery-stage dsRNA therapeutic candidate for the treatment of certain cancers.



Features

AI Copilot for Stock & Crypto

Resources